https://www.selleckchem.com/pr....oducts/gsk923295.htm
Our patient has remained free of tumor recurrence at year 2 postoperative visit. Our case highlights the need to choose a cost-effective treatment for ocular surface squamous neoplasia in an at-risk population among undocumented and uninsured patients. Areas in the world with similar types of populations or treatment challenges may need to consider this approach as a primary treatment option. Our case highlights the need to choose a cost-effective treatment for ocular surface squamous neoplasia in an at-risk population among undocumen
Like
Comment
Share
